The aging population poses a great challenge to the healthcare sector. Statistics from the United Nations show that the number of people living beyond 60 will double by 2050 worldwide [1]. At the same time, vascular diseases such as acute and chronic circulatory disorders in particular are on the rise.

This situation is our motivation for the further development and improvement of treatment options in the field of interventional vascular diagnostics and therapy. The intensive exchanges and constructive dialog we enjoy with our partners in hospitals and medicine bring us new possibilities, for example, Coroflex® ISAR, a drug-eluting stent system with an innovative polymer-free matrix coating. We are committed to providing safe, effective, innovative and indication-driven system solutions for the prevention, diagnosis, and treatment of vascular diseases at low cost.

In Pakistan, we also comply to regulations governed by Ministry of National Health Services, Regulations & Coordination, under Section 41 of DRAP Act, 2012 for cardiac stents products.